Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-26 @ 1:18 AM
Study NCT ID:
NCT04854434
Status:
TERMINATED
Last Update Posted:
2023-11-03
First Post:
2021-04-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety and Efficacy of Selinexor With or Without Pembrolizumab Versus Standard of Care in Previously Treated Metastatic Colorectal Cancer With RAS Mutations
Sponsor:
Karyopharm Therapeutics Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-29
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-24
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-17
First Submit QC Date:
None
Study First Post Date:
2021-04-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-07-31
Results First Submit QC Date:
None
Results First Post Date:
2023-11-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-10
Last Update Post Date:
2023-11-03
Last Update Post Date Type:
ACTUAL